CMR Surgical’s private round is the largest ever venture deal for a European medtech. And the point is to get to profitability, not flotation.
If its study of lung denervation hits, Nuvaira could get US approval and maybe swing a trade sale.
Feasibility trial success could mean a new therapy, but not for a few years yet.
The data are positive, but might not do much for the company’s sales.
Deal is the fifth largest robotics surgery purchase ever, and the second big move from Stryker.
Having succeeded with cystic fibrosis Vertex is now chasing a cure for type 1 diabetes.
Carmat says its artificial heart is the best such device in existence. But time is short, and so is money.
Before today’s trial readout no one was sure how remote ischaemic conditioning worked; now the investigators are pretty certain that it doesn’t.
Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.